Menu
Not yet recruiting NCT07203157

HEAL-SLE: Holistic Energy for Alleviating Lupus Symptoms

No phase Interventional Systemic Lupus Erythematosus

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Virtual Reiki Therapy.
Who it may be relevant to
Registry conditions: Systemic Lupus Erythematosus. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

A Pilot Study Evaluating the Effect and Feasibility of Virtual Reiki Therapy as a Complementary Treatment for Patients With Systemic Lupus Erythematosus

Overview

The purpose of this study is to assess the efficacy, feasibility, and acceptability of Virtual Reiki therapy as a complementary treatment for patients with systemic lupus erythematosus (SLE). The study also aims to investigate the feasibility, acceptability, and adherence of integrating Virtual Reiki therapy within the healthcare system for patients with SLE. Participants receiving standard of care (SOC) treatment for SLE will continue SOC while receiving research-specific Virtual Reiki therapy once per week for 8 weeks. Each study session will be delivered remotely by a Certified Reiki Practitioner Level II or higher.

Interventions

  • Other Virtual Reiki Therapy
    20-minute session once per week for 8 weeks via Webex. Each session will be delivered remotely by a Certified Reiki Practitioner Level II or higher.

Primary outcome measures

  • Change in Visual Analog Scales (VAS) score [Time frame: Baseline, Week 4]
  • Change in Visual Analog Scales (VAS) score [Time frame: Week 4, Week 8]
Secondary outcome measures (1)
  • Number of Reiki sessions completed over the 8-week period [Time frame: Week 8]

Eligibility criteria

Inclusion criteria

  • Adult aged 18 and older at the time of informed consent
  • Diagnosed with SLE (based on 2019 American College of Rheumatology (ACR)/ European League Against Rheumatism (EULAR) criteria)
  • Currently receiving SOC treatment for SLE at NYU Langone Orthopedic Center
  • Able and willing to provide consent and participate in 8 weekly virtual Reiki sessions
  • Has access to reliable internet, have an active email address, and able to utilize WebEx
  • Able to read, speak and understand English

Exclusion criteria

  • Under 18 years of age
  • Patients experiencing severe disease activity requiring hospitalization at time of screening
  • Unable to read, speak and understand English
  • No access to internet
  • Not willing to participate in weekly virtual Reiki sessions
  • Currently enrolled in another interventional clinical trial

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 1 center
  • NYU Langone Health — New York

Identifiers

NCT: NCT07203157 · 25-00357

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗